000 01293 a2200397 4500
005 20250513020422.0
264 0 _c19820128
008 198201s 0 0 eng d
022 _a0300-5623
024 7 _a10.1007/BF00256893
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrossman, H B
245 0 0 _aAndrogen stimulated chemotherapy in the Dunning R-3327 prostatic adenocarcinoma.
_h[electronic resource]
260 _bUrological research
_c1981
300 _a237-40 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAndrogens
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBody Weight
650 0 4 _aCastration
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aMale
650 0 4 _aMethotrexate
_xtherapeutic use
650 0 4 _aNeoplasms, Experimental
_xdrug therapy
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aRats
650 0 4 _aTestosterone
_xtherapeutic use
650 0 4 _aTime Factors
700 1 _aKleinert, E L
700 1 _aLesser, M L
700 1 _aHerr, H W
700 1 _aWhitmore, W F
773 0 _tUrological research
_gvol. 9
_gno. 5
_gp. 237-40
856 4 0 _uhttps://doi.org/10.1007/BF00256893
_zAvailable from publisher's website
999 _c7302859
_d7302859